Posted by pae on 27th June 2014
Those with progressive MS suffer from Mood and Anxiety Disorders at the rate of 3-4x that of the general population. Behavioral medicine is often an important and necessary component in the interdisciplinary treatment of MS. Patients and family members might find the disease difficult to fathom, as they may feel that hopes, dreams, and goals for the future will drastically change. Individuals and family members may react in a number of different ways, including, but not limited to: grief, anxiety, anger, depression, fear, numbness, denial, hopelessness, and in the worst case suicidal ideation or intent. This program will cover the important psychological factors associated with Progressive MS as well as methods for treatment.
Amy Burleson Sullivan, PsyD, is a health psychologist, and director of behavioral medicine, fellowship training and research at Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research. Dr. Sullivan’s specialty interests include consultation-liaison work, individual and family chronic disease management, pain management, depression and adjustment to phases of life.